Clinical Trial Update: Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical trial at Chinese PLA General Hospital to evaluate mesenchymal stem cell transfusion for refractory lupus nephritis; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Mesenchymal stem cell transfusion

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Lupus Nephritis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING